Nanotech 2010 Vol. 3
Nanotech 2010 Vol. 3
Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy

Cancer Nanotechnology Chapter 6

Detection of Cancer Related DNA Nanoparticulate Biomarkers and Nanoparticles in Whole Blood

Authors: M.J. Heller, R. Krishnan, A. Sonnenberg

Affilation: University of California San Diego, United States

Pages: 372 - 375

Keywords: cancer, nanomedicine, nanoparticles, diagnostics, biomarkers

Abstract:
The ability to rapidly detect DNA nanoparticulate biomarkers and drug delivery nanoparticles directly in blood is a major challenge for early disease detection and nanomedicine. We now show that a microarray dielectrophoretic (DEP) device can be used to rapidly isolate and detect high molecular weight (hmw) DNA nanoparticulates and nanoparticles directly from whole blood. At DEP frequencies of 5kHz-10kHz both fluorescent-stained hmw-DNA and 40nm fluorescent nanoparticles separate from the blood and become highly concentrated at specific DEP high field regions over the microelectrodes, while blood cells move to the DEP low field regions. The blood cells can then be removed by a simple fluidic wash while the hmw-DNA and nanoparticles remain highly concentrated. The hmw-DNA could be detected at a level of <260ng/ml, and the nanoparticles at <9.5 x 109 particles/ml, detection levels that are well within the range for viable clinical diagnostics and drug nanoparticle monitoring. Hmw-DNA could also be detected directly in blood from patients with Chronic Lymphocytic Leukemia (CLL)

Detection of Cancer Related DNA Nanoparticulate Biomarkers and Nanoparticles in Whole Blood

ISBN: 978-1-4398-3415-2
Pages: 880
Hardcopy: $189.95